Eli Lilly & Company Built an AI Supercomputer to Ask Bigger Questions

What changes when scientists stop thinking about how much compute they can afford to use and start thinking about what they could discover with more of it? That question sits behind LillyPod, Eli Lilly & Company’s on-prem AI supercomputer. Chief AI Officer Dr. Thomas Fuchs sees compute less as infrastructure and more as a scientific instrument, something that allows researchers to work at a scale that changes not only the answers they can find, but the questions they’re willing to ask. &n...